Childhood Eczema Challenge Grant


Nearly 10 million U.S children under the age of 18 are affected by eczema, with one‐third affected by moderate‐to‐severe disease. Despite recent therapeutic advances, the burdens on these patients, and their families, can be significant and many important research questions remain unanswered.  

To address this need, the National Eczema Association (NEA) and the Pediatric Dermatology Research Alliance (PeDRA) are collaborating to support targeted clinical research investigations focused on pediatric eczema with the Childhood Eczema Challenge Grant. Through this grant NEA and PeDRA intend to accelerate research that improves the health and quality of life of pediatric eczema patients and their families.  


This Challenge Grant is intended to stimulate early and mid-career scientists as they seek to build and sustain careers as research investigators and future thought leaders within this critical field of study.  Research proposals should address at least one of the following priorities related to pediatric eczema:

  • Eczema Heterogeneity:  Novel Insights
    Projects aimed at advancing understanding of the underlying factors contributing to the diversity of pediatric eczema clinical presentation, treatment response and comorbidities.
  • Innovations in Clinical Practice & Care
    Studies addressing approaches to facilitate optimal identification and treatment of pediatric eczema and associated comorbidities in all health care settings to enhance patient/caregiver-reported and patient/caregiver-centric outcomes.  
  • Understanding & Alleviating Disease Burden
    Insightful proposals that identify, quantify, or aim to reduce aspects of pediatric eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic, occupational, or economic impacts) based on patient population, treatment approach, etc.
  • Eczema Prevention
    Novel investigations into the potential risk factors and strategies of primary eczema prevention in the pediatric population.

Priority will be given to proposals that focus on clinical or translational research, are broadly applicable, and include a patient-centered or comparative effectiveness framework. Applications that support NEA’s and PeDRA’s commitment to advancing equity, diversity, and inclusion across all facets of their organizations and research are encouraged.  Proposals that include basic research will be accepted, however, they should be combined with a significant clinical or translational component. Proposals related to the development or enhancement of mobile apps will not be accepted. 

Number of Awards

One (1) Challenge Grant is available for the 2024 funding cycle.  This is a one‐year non‐renewable grant, with an expected start date of January 1, 2025.  


Early and mid‐career investigators (Associate Professor level or below and within 15 years of finishing training) are eligible to apply. Applicants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution. Applications may be submitted by either a single investigator or multiple investigators at multiple institutions. Applicants need not be United States citizens and the research need not be conducted in the United States. Applicants may not hold current R‐level funding from NIH (or equivalent) as PI or Co‐PI, however recipients of past or current NEA and/or PeDRA grants are eligible to apply. 


Applicants may request up to $50,000 (USD; direct costs only). Indirect costs are not allowed.  Salary and fringe benefit support is allowed. Staff salary support should be commensurate with the percent effort dedicated to the project and explained in budget justification.  PI salary support must adhere to the current allowable NIH salary cap

How To Apply

Review and download the NEA Childhood Eczema Challenge Research Grant Application. See the NEA grant conditions of award and frequently asked questions for additional award information and requirements.

The following steps will need to be taken in order to successfully submit your NEA research grant application for review:

  1.  Fill out the research grant application in its entirety.
  2.  Make sure your document is merged with all relevant documentation.
  3.  Submit your NEA Research Grant Application via our APPLICATION PORTAL. Please fill out all the required fields in our online research grant intake form.   
  4.  The application portal is where you can upload your application and any supporting documentation to NEA.
  5.  You will be given an email confirmation when we receive your application.  If you do not receive an email confirmation, please check your Junk folder.

Completed applications must be received by Wednesday, July 31, 2024 at 5 p.m. PDT. NO EXCEPTIONS can be made to this deadline.

Award notifications are anticipated after November 30, 2024.

Email with any additional questions on this award or the award process.

Download Application

Important Dates

Application deadline: 5:00PM PDT, Wednesday, July 31, 2024 

Awards Made: After November 30, 2024

Earliest Start Date: January 1, 2025


Email or for additional information or with any questions on the Challenge Grant, application, or review process.

About the National Eczema Association (NEA)

Founded in 1988, the NEA is the largest, 501(c)(3) non‐profit, US patient advocacy organization serving people affected by eczema.  NEA is the driving force for an eczema community fueled by knowledge, strengthen through collective action and propelled by the promise for a better future.

About the Pediatric Dermatology Research Alliance (PeDRA)

Formed in 2012, the Pediatric Dermatology Research Alliance (PeDRA) is a nonprofit research network with the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

NEA Research Banner
NEA is the largest private nonprofit funder of research for adult and pediatric eczema, investing more than $4 million to date. We are dedicated to increasing the number of scientists, research projects and research dollars devoted to eczema, in pursuit of better therapies, better care, better outcomes –– and one day, potentially, a cure.
Applying Organization Details

If US based, use two letter abbreviation.

Principal Investigator Details

If US based, use two letter abbreviation.

Institutional Representative Details

If your grant application is approved, the institutional representative will receive the grant agreement for electronic signature first.

Grant Details

Get the latest eczema news delivered to your inbox.